Heparin-induced thrombocytopenia: Advances in diagnosis and treatment

Critical Care Nurse

Volumn 26, Issue 6, 2006, Pages 30-36

  Cooney, Maureen F ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; HEPARIN; HIRUDIN DERIVATIVE; LEPIRUDIN; PIPECOLIC ACID DERIVATIVE; RECOMBINANT PROTEIN;

CHEMICALLY INDUCED DISORDER; DRUG MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; INTENSIVE CARE; INTERNATIONAL NORMALIZED RATIO; METHODOLOGY; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; ORAL DRUG ADMINISTRATION; PARTIAL THROMBOPLASTIN TIME; PATIENT SELECTION; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SYNDROME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TIME;

ADMINISTRATION, ORAL; ANTICOAGULANTS; CRITICAL CARE; DRUG MONITORING; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARIN; HIRUDINS; HUMANS; INTERNATIONAL NORMALIZED RATIO; NURSE'S ROLE; NURSING ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PATIENT SELECTION; PIPECOLIC ACIDS; PLATELET COUNT; PRACTICE GUIDELINES; RECOMBINANT PROTEINS; RISK FACTORS; SYNDROME; THROMBOCYTOPENIA; TIME FACTORS;

EID: 36749101091     PISSN: 02795442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jang IK, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation. 2005;111: 2671-2683.
2. Fahey VA. Heparin-induced thrombocytopenia. J Vasc Nurs. 1995;13:112-116.
3. Rice L. Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you and your patient). Arch Intern Med. 2004;164:1961-1964.
4. Levine RL. Finding haystacks full of needles: from Opus to Osler. Chest. 2005;127: 1488-1490.
5. Begelman SM, Hursting MJ, Aghababian RV, McCollum D. Heparin-induced thrombocytopenia from venous thromboembolism treatment. J Intern Med. 2005;258:563-572.
6. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):311S-337S.
7. Francis JL, Palmer GJ, Moroose R, Drexler A. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Ann Thorac Surg. 2003;75:17-22.
8. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330-1335.
9. Gruel Y, Pouplard C, Nguyen P, et al. Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia. Br J Haematol. 2003;121:786-792.
10. McNulty I, Katz E, Kim KY. Thrombocytopenia following heparin flush. Prog Cardiovasc Nurs. 2005;20:143-147.
11. Greinacher A, Eichler P, Lietz T, Warkentin TE. Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia. Blood. 2005;106:2921-2922.
12. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 2000;96:1703-1708.
13. Rice L, Attisha WK, Francis JL. Delayed-onset heparin-induced thrombocytopenia [letter]. Ann Intern Med. 2003;139:790-791.
14. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003;121:535-555.
15. Warkentin TE, Hayward CPM, Boshkov LK, et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood. 1994;84:3691-3699.
16. Hirsh J, Heddle N, Kelton JG. Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med. 2004;164:361-369.
17. Warkentin TE. Heparin-induced thrombocytopenia: a clinicopathologic syndrome. Thromb Haemost. 1999;82:439-447.
18. Kiefel V. Differential diagnosis of acute thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-Induced Thrombocytopenia. 3rd ed. New York, NY: Marcel Dekker Inc; 2004:25-52.
19. Warkentin TE. Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia: recommendations of the College of American Pathologists. Arch Pathol Lab Med. 2002;126:1415-1423.
20. Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep. 2003;2:148-157.
21. Lubenow N, Kempf R, Eichner A, Eichlet P, Carlsson LE, Greinacher A. Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin. Chest. 2002; 122:37-42.
22. DeEugenio DL, Ruggiero N, Thomson LJ, et al. Early-onset heparin-induced thrombocytopenia after a 165-day heparin-free interval: case report and review of the literature. Pharmacotherapy. 2005;25:615-619.
23. Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med. 2002;136:210-215.
24. Smythe MA, Stephens JL, Mattson JC. Delayed-onset heparin-induced thrombocytopenia. Ann Emerg Med. 2005;45:417-419.
25. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med. 2001;135: 502-506.
26. Warkentin TE, Roberts RS, Hirsh J, et al. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med. 2003; 163:2518-2524.
27. Warkentin TE, Elavathil LJ, Hayward CP, Johnston MA, Russett JI, Kelton JG. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med. 1997; 127:804-812.
28. Srinivasan AF, Rice L, Bartholomew JR, et al. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. Arch Intern Med. 2004;164:66-70.
29. Matthai WH, Hursting MJ, Lewis BE, Kelton JG. Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia. Thromb Res. 2005;116:121-126.